Skip to main content
Clinical Trials/CTRI/2021/09/036872
CTRI/2021/09/036872Not yet recruitingPhase 2

Comparative study of Virechana and Shamana Chikitsa in Vicharchika W.S.R to Eczema.

Dr Neha1 site in 1 country50 target enrollmentStarted: September 29, 2021Last updated:

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
50
Locations
1
Primary Endpoint
Assessed by change in the signs and symptoms of vicharchika

Study Overview

Brief Summary

Eczema patients will be selected according to signs and symptoms i.e 50 patients will be selected and divided into two groups each consists of 25 patients and conduct a clinical study to find whether is there any difference between Virechana procedure followed by Eladi lepa and followed by Navakashaya in the management of Vicharchika w.s.r to Eczema and evaluate the efficacy of virechana followed by Eladi lepa and followed by Navakashaya and compare the efficacy and safety of both.

Study Design

Study Type
Interventional
Allocation
Random Number Table
Masking
Open Label

Eligibility Criteria

Ages
20.00 Year(s) to 60.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Patients willing for trial, diagnosed Eczema on the basis of signs & symptoms and fit for Virechana and Shamana treatment.

Exclusion Criteria

  • Patients less than 20 years & more than 60years,infected patch and pus collection, secondary infection, chronic diseases, malignancy, pregnant, lactating women and unfit patients for Virechana & Shamana treatment.

Outcomes

Primary Outcomes

Assessed by change in the signs and symptoms of vicharchika

Time Frame: 50 days

Secondary Outcomes

  • Assessed by change in the objective parameters(50 days)

Investigators

Sponsor
Dr Neha
Sponsor Class
Other [[Self ( Dr Neha MD Scholar)]]

Study Sites (1)

Loading locations...

Similar Trials